Neurons in CTE carry mutation patterns seen in Alzheimer's. Head impacts alone did not

Chronic traumatic encephalopathy is linked to exposure to repetitive head impacts, but very little is known about how the disease actually starts [s1]. A study published in Science on 30 October went looking inside individual neurons for an answer, and found one that complicates the simplest version of the story: the genomic damage tracked the disease, not the exposure [s1].

What was done

The researchers applied two single-cell whole-genome sequencing methods to hundreds of neurons taken from the prefrontal cortex of 15 individuals with CTE and 4 individuals who had a history of repetitive head impacts but did not have CTE [s1].

That second group is the design choice that makes the study informative. Comparing CTE brains against uninjured brains would show differences without distinguishing the effects of the hits from the effects of the disease. Including people who took the hits and did not develop the pathology separates the two.

What was found

Neurons from people with CTE carried increased somatic single-nucleotide variants — mutations acquired during life rather than inherited — following a pattern previously reported in Alzheimer's disease [s1].

In a subset of the CTE individuals, the researchers also found high burdens of somatic small insertions and deletions, resembling a known mutational pattern designated ID4 that has likewise been found in Alzheimer's disease [s1].

Neurons from the four people with repetitive head impacts but no CTE did not show similar changes [s1].

The authors' reading is twofold: neurons in CTE experience stereotyped mutational processes shared with Alzheimer's disease, and the absence of those changes in head-impact-exposed neurons without CTE suggests CTE involves mechanisms beyond repetitive head impacts alone [s1].

How much weight this can carry

Fifteen and four. Those are the numbers, and they should govern how the finding is read.

Single-neuron whole-genome sequencing was applied here to hundreds of cells drawn from the 15 CTE brains and 4 comparison brains [s1]; the constraint is the number of brains, not the number of cells. Four control brains cannot establish that people with heavy head-impact exposure and no CTE reliably lack these mutations. The comparison is suggestive, not settled.

The study is also cross-sectional and post-mortem. It observes the genomes of neurons at the end of a life, and it cannot say whether the mutations preceded the pathology, accompanied it, or followed it. "Mechanisms beyond repetitive head impacts alone" is a claim about what is present, not about the order in which things happened [s1].

And the mutational signatures are shared with Alzheimer's disease, which is a finding about pattern, not about cause. Two diseases can converge on similar genomic damage through different routes.

The other window into the same tissue

A separate study published earlier this year took a different approach to the same problem. Using Visium spatial transcriptomics, researchers mapped gene expression inside discrete CTE lesions and in matched normal tissue from the same individuals [s2].

They derived a common 21-gene signature of CTE lesions, highlighting astrocytic activation, neuroinflammation, blood-brain barrier function and extracellular matrix remodelling as key features [s2]. Almost all the signature genes were strongly expressed in astrocytes, and ontological and protein association analyses implicated extracellular matrix functions as drivers of the disease [s2]. The authors describe the result as a first glimpse into the molecular dynamics of CTE lesions in situ, and offer the 21 molecules as candidates for developing an in-life diagnostic [s2].

That last point is the practical stake in all of this. CTE is clinically ambiguous and at present can only be diagnosed post-mortem [s2]. Every question that matters to a living former athlete — do I have it, how far along is it, will it progress — is currently unanswerable, and both of these studies are attempts to build the biology that a future answer would rest on.

What the two studies do and do not agree on

They are looking at different things: one at genomes in neurons, the other at gene expression in lesions, mostly in astrocytes [s1][s2]. Neither confirms the other, and neither was designed to.

What they share is a direction. Both suggest that CTE has molecular characteristics distinguishable from head trauma as such — a stereotyped process rather than simply the accumulated record of impacts [s1][s2]. If that holds, it changes what the disease is understood to be, and it changes what a diagnostic test would need to look for.

What to watch

Larger cohorts, particularly larger comparison groups of head-impact-exposed people without CTE, which is the specific number this study is short of [s1]. Whether the ID4 insertion-deletion pattern appears in more than a subset of cases [s1]. And whether any of the 21 candidate genes survives the long journey from tissue signature to a measurable signal in a living person [s2].

Neither study says anything about whether any individual person has CTE, and neither offers guidance on participation in contact sport.

Sources

• [s1] Diverse somatic genomic alterations in single neurons in chronic traumatic encephalopathy, Science, 30 October 2025. https://doi.org/10.1126/science.adu1351
• [s2] Spatially resolved transcriptomics reveals a unique disease signature and potential biomarkers for chronic traumatic encephalopathy, Journal of Neuropathology & Experimental Neurology, 18 July 2025. https://doi.org/10.1093/jnen/nlaf078